ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Discontinuing Surveillance of Low‐Risk Branch‐Duct Intraductal Papillary Mucinous Neoplasms in Routine Practice: An External Application of the “Trivial” Criteria and the Resources it Would Release in Fourteen Health Systems

Study limitation reported by the research below: “Economic estimates are not transferable across health systems: the identical surveillance pattern cost €79/person-year in Japan vs €318 in Sweden, producing a fourfold range in projected savings — local recalculation is essential before applying these figures.”

Papers